KAPLAN_USMLE_STEP_1_LECTURE_NOTES_2018_BIOCHEMISTRY_and_GENETICS
.pdf
Chapter 18 ● Purine and Pyrimidine Metabolism
PURINE CATABOLISM AND THE SALVAGE ENZYME HGPRT
Excess purine nucleotides or those released from DNA and RNA by nucleases are catabolized first to nucleosides (loss of Pi) and then to free purine bases (release of ribose or deoxyribose). Excess nucleoside monophosphates may accumulate when:
•RNA is normally digested by nucleases (mRNAs and other types of RNAs are continuously turned over in normal cells).
•Dying cells release DNA and RNA, which is digested by nucleases.
•The concentration of free Pi decreases as it may in galactosemia, hereditary fructose intolerance, and glucose-6-phosphatase deficiency.
Salvage enzymes recycle normally about 90% of these purines, and 10% are converted to uric acid and excreted in urine. When purine catabolism is increased significantly, a person is at risk for developing hyperuricemia and potentially gout.
Purine catabolism to uric acid and salvage of the purine bases hypoxanthine (derived from adenosine) and guanine are shown below.
|
|
HGPRT deficiency (Lesch-Nyhan syndrome) |
|||
|
|
|
• Spastic cerebral palsy |
|
|
|
|
|
• Self-mutilation (hands, lips) |
|
|
|
|
|
• Hyperuricemia and gout |
|
|
|
|
|
• Early death |
|
|
ATP, GTP |
AMP |
IMP |
• X-linked (recessive) |
|
|
High-energy compounds |
|
|
|
|
|
DNA and RNA |
|
GMP |
|
|
Salvage |
|
|
|
|
|
pathway |
Pi |
|
NH3 |
Ribose-P |
|
HGPRT |
|
|
(HPRT) |
|||
|
|
|
|
|
|
AMP |
Adenosine |
Inosine |
|
Hypoxanthine |
90% |
|
Adenosine |
Purine |
|
||
|
|
|
|||
|
deaminase |
nucleoside |
and |
|
|
|
|
|
phosphorylase |
or |
|
GMP |
|
Guanosine |
Guanine |
|
|
|
Pi |
|
Ribose-P |
|
Xanthine |
|
|
|
|
||
|
Allopurinol |
|
|
– |
Excretion pathway |
||
|
|
|
Xanthine oxidase |
||||
|
|
|
|
|
|
||
Adenosine deaminase (ADA) deficiency |
Dietary purines converted to uric |
|
|
10% |
|||
• Severe combined immunodeficiency |
acid by enterocytes and added to |
|
|
|
|
|
|
|
|
|
Uric acid |
|
|||
• Autosomal recessive |
the blood for excretion in the urine |
|
|
||||
|
|
|
|
||||
Figure I-18-5. Purine Excretion and Salvage Pathways
295
Part I ● Biochemistry
Review Questions
Select the ONE best answer.
1.A 6-month-old boy becomes progressively lethargic and pale and shows delayed motor development. Laboratory evaluation reveals normal blood urea nitrogen (BUN), low serum iron, hemoglobin 4.6 g/dL, and leukopenia. His bone marrow shows marked megaloblastosis, which did not
respond to treatment with iron, folic acid, vitamin B12, or pyridoxine. His urine developed abundant white precipitate identified as orotic acid. The underlying defect causing the megaloblastic anemia in this child is most likely in which of the following pathways?
A.Homocysteine metabolism
B.Pyrimidine synthesis
C.Urea synthesis
D.Uric acid synthesis
E.Heme synthesis
2.Patients with Lesch-Nyhan syndrome have hyperuricemia, indicating an increased biosynthesis of purine nucleotides, and markedly decreased levels of hypoxanthine phosphoribosyl transferase (HPRT). The hyperuricemia can be explained on the basis of a decrease in which regulator of purine biosynthesis?
A.ATP
B.GDP
C.Glutamine
D.IMP
E.PRPP
3.A 12-week-old infant with a history of persistent diarrhea and candidiasis is seen for a respiratory tract infection with Pneumocystis jiroveci. A chest x-ray confirms pneumonia and reveals absence of a thymic shadow. Trace IgG is present in his serum, but IgA and IgM are absent. His red blood cells completely lack an essential enzyme in purine degradation. The product normally formed by this enzyme is
A.guanine monophosphate
B.hypoxanthine
C.inosine
D.xanthine
E.xanthine monophosphate
298
Chapter 18 ● Purine and Pyrimidine Metabolism
Items 4 and 5
The anticancer drug 6-mercaptopurine is deactivated by the enzyme xanthine oxidase. A cancer patient being treated with 6-mercaptopurine develops hyperuricemia, and the physician decides to give the patient allopurinol.
4.What effect will allopurinol have on the activity of 6-mercaptopurine?
A.Enhanced deactivation of 6-mercaptopurine
B.Enhanced elimination of 6-mercaptopurine as uric acid
C.Enhanced retention and potentiation of activity
D.Decreased inhibition of PRPP glutamylamidotransferase
5. Resistance of neoplastic cells to the chemotherapeutic effect of 6-mercaptopurine would most likely involve loss or inactivation of a gene encoding
A.thymidylate synthase
B.hypoxanthine phosphoribosyltransferase
C.purine nucleoside pyrophosphorylase
D.orotic acid phosphoribosyltransferase
E.adenosine deaminase
299
Part I ● Biochemistry
Answers
1.Answer: B. Accumulation of orotic acid indicates megaloblastic anemia arises because pyrimidines are required for DNA synthesis.
2.Answer: D. IMP is a feedback inhibitor of PRPP amidophosphoribosyl transferase, the first reaction in the biosynthesis of purines. IMP is formed by the HPRT reaction in the salvage of hypoxanthine.
3.Answer: C. The child most likely has severe combined immunodeficiency caused by adenosine deaminase deficiency. This enzyme deaminates adenosine (a nucleoside) to form inosine (another nucleoside). Hypoxanthine and xanthine are both purine bases, and the monophosphates are nucleotides.
4.Answer: C. Because allopurinol inhibits xanthine oxidase, the 6-mercaptopurine will not be deactivated as rapidly.
5.Answer: B. HPRT is required for activation of 6-mercaptopurine to its ribonucleotide and inhibition of purine synthesis. The other enzymes listed are not targets for this drug.
300
PART II
Medical Genetics
